The company's financial position appears increasingly strained, with equity falling to negative $14.6 million by 2025Q4 and a current ratio of 0.73 as of 2026Q1 indicating potential liquidity pressure.
| Total Current Assets | 61.54M | 82.39M | 69.08M | 58.43M | 81.11M | 106.65M | 28.95M | 22.8M |
| Cash & Short-Term Investments | 38.1M | 54.6M | 43.84M | 41.17M | 68.15M | 85.83M | 11.74M | 13.94M |
| Cash Only | 11.67M | 33.9M | 13.68M | 13.7M | 37.42M | 85.83M | 11.74M | 13.94M |
| Short-Term Investments | 26.43M | 20.7M | 30.16M | 27.48M | 30.73M | 0 | 0 | 0 |
| Accounts Receivable | 14.69M | 19.18M | 20.77M | 12.63M | 7.93M | 17.34M | 14.9M | 7.06M |
| Days Sales Outstanding | 81.92 | 99.21 | 131.36 | 85.87 | 57.43 | 167.11 | 170.97 | 81.78 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.74M | 8.61M | 4.47M | 2.22M | 2.4M | 1.2M | 2.31M | 1.72M |
| Total Non-Current Assets | 78.34M | 32.64M | 37.05M | 44.37M | 34.4M | 13.8M | 13.78M | 4.02M |
| Property, Plant & Equipment | 8.76M | 7.79M | 7.86M | 10.03M | 5.5M | 5.2M | 5.12M | 2.92M |
| Fixed Asset Turnover | 9.08x | 9.06x | 7.35x | 5.35x | 9.16x | 7.28x | 6.22x | 10.77x |
| Goodwill | 35.2M | 4.18M | 4.18M | 4.18M | 4.22M | 2.68M | 2.68M | 0 |
| Intangible Assets | 19.55M | 2.17M | 3.02M | 3.86M | 4.58M | 2.96M | 3.41M | 0 |
| Long-Term Investments | 50.15M | 4.95M | 14.6M | 20.3M | 16.32M | 0 | 0 | 0 |
| Other Non-Current Assets | 11.06M | 13.56M | 7.4M | 6M | 3.79M | 2.96M | 2.58M | 1.1M |
| Total Assets | 139.88M | 115.03M | 106.14M | 102.8M | 115.52M | 120.44M | 42.74M | 26.82M |
| Asset Turnover | 0.66x | 0.61x | 0.54x | 0.52x | 0.44x | 0.31x | 0.74x | 1.17x |
| Asset Growth % | 71.81% | 8.38% | 3.24% | -11.01% | -4.09% | 181.83% | 59.33% | - |
| Total Current Liabilities | 84.52M | 73.2M | 59.28M | 46.4M | 43.67M | 42.49M | 28.23M | 19.22M |
| Accounts Payable | 563K | 340K | 539K | 183K | 572K | 1.72M | 1.12M | 702K |
| Days Payables Outstanding | 22.42 | 18 | 33 | 13.16 | 48.77 | 168.46 | 273.2 | 137.61 |
| Short-Term Debt | 1.37M | 2.4M | 2.4M | 2.07M | 1.26M | 833K | 1.2M | 1.01M |
| Deferred Revenue (Current) | 195.66M | 51.37M | 41.62M | 32.72M | 31.71M | 30.07M | 0 | 0 |
| Other Current Liabilities | 27.86M | 19.09M | 4.68M | 333K | 0 | 0 | 18.97M | 14.34M |
| Current Ratio | 0.73x | 1.13x | 1.17x | 1.26x | 1.86x | 2.51x | 1.03x | 1.19x |
| Quick Ratio | 0.73x | 1.13x | 1.17x | 1.26x | 1.86x | 2.51x | 1.03x | 1.19x |
| Cash Conversion Cycle | 59.5 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 52.76M | 56.46M | 48.04M | 41.3M | 34.31M | 25.05M | 20.81M | 11.32M |
| Long-Term Debt | 4.09M | 3.57M | 594K | 1.29M | 448K | 266K | 727K | 838K |
| Capital Lease Obligations | 10.28M | 3.12M | 3M | 3.61M | 1.01M | 1.85M | 2.08M | 1.52M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 48.68M | -647K | 1.64M | 2.41M | 1.02M | 2.16M | 18M | 8.97M |
| Total Liabilities | 137.28M | 129.66M | 107.32M | 87.7M | 77.98M | 67.54M | 49.03M | 30.54M |
| Total Debt | 5.46M | 9.08M | 5.99M | 7.75M | 3.62M | 3.91M | 4.77M | 3.85M |
| Net Debt | -6.21M | -24.82M | -7.69M | -5.94M | -33.8M | -81.91M | -6.97M | -10.09M |
| Debt / Equity | 2.11x | - | - | 0.51x | 0.10x | 0.07x | - | - |
| Debt / EBITDA | -0.18x | - | - | - | - | - | - | 0.48x |
| Net Debt / EBITDA | 0.21x | - | - | - | - | - | - | -1.26x |
| Interest Coverage | -181.46x | -171.69x | -115.56x | -149.69x | -308.21x | -37.59x | -43.68x | 25.08x |
| Total Equity | 2.59M | -14.63M | -1.19M | 15.1M | 37.53M | 52.9M | -6.3M | -3.72M |
| Equity Growth % | -1838.92% | -1131.65% | -107.87% | -59.76% | -29.05% | 940.28% | -69.34% | - |
| Book Value per Share | 0.06 | -0.35 | -0.03 | 0.42 | 1.15 | 2.41 | -0.20 | -0.17 |
| Total Shareholders' Equity | 2.59M | -14.63M | -1.19M | 15.1M | 37.53M | 52.9M | -6.3M | -3.72M |
| Common Stock | 46K | 44K | 40K | 37K | 34K | 31K | 18K | 17K |
| Retained Earnings | -179.59M | -171.63M | -136.88M | -103.25M | -66.38M | -38.99M | -15.61M | -12.35M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 121K | 179K | 135K | 120K | 101K | -81K | -31K | -18K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and Capital Dilution
As reported in recent financial statements, Arteris has seen its equity position collapse from a positive $15.1 million in 2023Q4 to a negative $14.6 million by 2025Q4, signaling a rapid erosion of book value driven by persistent operating losses and aggressive investment in R&D.
The consistent decline in retained earnings, which reached -$179.6 million in 2026Q1, suggests that the company is consuming its capital base to fund growth rather than generating internal returns. Investors should monitor whether this trajectory necessitates further dilutive equity raises to maintain operational continuity.
Based on the 2026Q1 balance sheet, the current ratio has compressed to 0.73, indicating that current liabilities now exceed current assets, which raises significant concerns regarding the company's ability to meet short-term obligations without external financing or a rapid improvement in cash collection cycles.
The volatility in cash balances, which dropped from $33.9 million in 2025Q4 to $11.7 million in 2026Q1, underscores the high-burn nature of the business model. This liquidity profile suggests a narrowing margin for error, particularly if licensing revenue recognition remains lumpy and unpredictable.
According to quarterly filings, deferred revenue has shown significant expansion, reaching $54.7 million in 2026Q1, which serves as a critical forward-looking indicator of future revenue recognition potential as multi-year licensing agreements move through the company's accounting pipeline.
While this backlog provides some visibility into future top-line performance, the disconnect between deferred revenue and actual cash on hand suggests that the company is effectively 'pre-selling' its future capacity. Analysts should evaluate whether these obligations can be fulfilled without incurring further significant operating costs.
Analysis of the balance sheet reveals that goodwill and intangible assets represent a substantial portion of total assets, which warrants investigation into potential impairment risks should the company's strategic acquisitions fail to deliver the anticipated synergies in the competitive semiconductor IP market.
The reliance on intangible assets to bolster the balance sheet may mask the underlying lack of tangible, liquid assets available to support operations. If the competitive landscape shifts, these assets may prove difficult to monetize, potentially leading to significant write-downs that would further impair the company's already negative equity position.
Quick answers to the most common questions about buying AIP stock.
As of 2025, Arteris, Inc. (AIP) had total assets of $115.0M including $82.4M in current assets.
Arteris, Inc. (AIP) carries total debt of $9.1M, offset by $54.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Arteris, Inc. (AIP) has total shareholders' equity (book value) of $-14.6M ($-0.35 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Arteris, Inc. (AIP) reported a current ratio of 1.13x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.